AI News, 3Shape TRIOS® Intraoral Scanner artificial intelligence

3Shape TRIOS 3 Basic

1 18 in vivo and in vitro studies (between 2015 and 2018).

The 3Shape name and logo and/or other trademarks mentioned herein, including “Go Beyond”, “Go Beyond ANALOG”, “Go Beyond SCANNING” and “Go Beyond TREATMENT” are trademarks of 3Shape A/S, registered in US and other countries.

TRIOS 3 POD INTRAORAL SCANNER

Impress your Patients Take advantage of the award-winning TRIOS intraoral scanner to enhance patient experience, reduce chair-time, and unlock new treatment opportunities.

Unlike many other solutions, TRIOS gives you continuous software updates, and optional dental treatment modules to ensure that your practice stays ahead as your business grows stronger.Portable, Lightweight Pod Handheld 3D Scanner with ultrafast Optical Sectioning Technology for Intraoral Scanning in Colors, Capable of Measuring shades of teeth & adding HD photos to the 3D ModelWith 3Shape TRIOS, you can enhance patient experience, reduce chair-time and unlock many new treatment opportunities.

Unlike many other solutions, TRIOS gives you continuous software updates, and optional dental treatment modules to ensure that your practice stays ahead as your business grows stronger.Portable, Lightweight Pod Handheld 3D Scanner with ultrafast Optical Sectioning Technology for Intraoral Scanning in Colors, Capable of Measuring shades of teeth & adding HD photos to the 3D ModelWith 3Shape TRIOS, you can enhance patient experience, reduce chair-time and unlock many new treatment opportunities.

AI for simpler scanning

1 18 in vivo and in vitro studies (between 2015 and 2018).

The 3Shape name and logo and/or other trademarks mentioned herein, including “Go Beyond”, “Go Beyond ANALOG”, “Go Beyond SCANNING” and “Go Beyond TREATMENT” are trademarks of 3Shape A/S, registered in US and other countries.

The PDS® Foundation’s Mobile Dental Clinic Provides Donated Dentistry to Patients at Bethlehem Center

These factors include, among other things, the ability to complete the initial public offering of Envista on the currently contemplated timeline or at all and achieve the intended benefits thereof, deterioration of or instability in the economy, the markets served by us and the financial markets, developments and uncertainties in U.S. policy stemming from the U.S. administration, such as changes in U.S. trade and tariff policies and the reaction of other countries thereto, contractions or growth rates and cyclicality of markets we serve, competition, our ability to develop and successfully market new products and technologies and expand into new markets, the potential for improper conduct by our employees, agents or business partners, our compliance with applicable laws and regulations (including regulations relating to medical devices and the health care industry), the results of our clinical trials and perceptions thereof, our ability to effectively address cost reductions and other changes in the health care industry, our ability to successfully identify and consummate appropriate acquisitions and strategic investments and successfully complete divestitures and other dispositions, our ability to integrate the businesses we acquire and achieve the anticipated benefits of such acquisitions, contingent liabilities relating to acquisitions, investments and divestitures (including tax-related and other contingent liabilities relating to past and future IPOs, split-offs or spin-offs), security breaches or other disruptions of our information technology systems or violations of data privacy laws, the impact of our restructuring activities on our ability to grow, risks relating to potential impairment of goodwill and other intangible assets, currency exchange rates, tax audits and changes in our tax rate and income tax liabilities, changes in tax laws applicable to multinational companies, litigation and other contingent liabilities including intellectual property and environmental, health and safety matters, the rights ofthe United Statesgovernment to use, disclose and license certain intellectual property we license if we fail to commercialize it, risks relating to product, service or software defects, product liability and recalls, risks relating to product manufacturing, the impact of our debt obligations on our operations and liquidity, our relationships with and the performance of our channel partners, uncertainties relating to collaboration arrangements with third-parties, commodity costs and surcharges, our ability to adjust purchases and manufacturing capacity to reflect market conditions, reliance on sole sources of supply, the impact of deregulation on demand for our products and services, labor matters, international economic, political, legal, compliance and business factors (including the impact of theUnited Kingdom'sdecision to leave the EU and uncertainty relating to the terms and timing of such separation), disruptions relating to man-made and natural disasters and pension plan costs.

These factors include, among other things, the ability to complete the initial public offering of Envista on the currently contemplated timeline or at all and achieve the intended benefits thereof, deterioration of or instability in the economy, the markets served by us and the financial markets, developments and uncertainties in U.S. policy stemming from the U.S. administration, such as changes in U.S. trade and tariff policies and the reaction of other countries thereto, contractions or growth rates and cyclicality of markets we serve, competition, our ability to develop and successfully market new products and technologies and expand into new markets, the potential for improper conduct by our employees, agents or business partners, our compliance with applicable laws and regulations (including regulations relating to medical devices and the health care industry), the results of our clinical trials and perceptions thereof, our ability to effectively address cost reductions and other changes in the health care industry, our ability to successfully identify and consummate appropriate acquisitions and strategic investments and successfully complete divestitures and other dispositions, our ability to integrate the businesses we acquire and achieve the anticipated benefits of such acquisitions, contingent liabilities relating to acquisitions, investments and divestitures (including tax-related and other contingent liabilities relating to past and future IPOs, split-offs or spin-offs), security breaches or other disruptions of our information technology systems or violations of data privacy laws, the impact of our restructuring activities on our ability to grow, risks relating to potential impairment of goodwill and other intangible assets, currency exchange rates, tax audits and changes in our tax rate and income tax liabilities, changes in tax laws applicable to multinational companies, litigation and other contingent liabilities including intellectual property and environmental, health and safety matters, the rights ofthe United Statesgovernment to use, disclose and license certain intellectual property we license if we fail to commercialize it, risks relating to product, service or software defects, product liability and recalls, risks relating to product manufacturing, the impact of our debt obligations on our operations and liquidity, our relationships with and the performance of our channel partners, uncertainties relating to collaboration arrangements with third-parties, commodity costs and surcharges, our ability to adjust purchases and manufacturing capacity to reflect market conditions, reliance on sole sources of supply, the impact of deregulation on demand for our products and services, labor matters, international economic, political, legal, compliance and business factors (including the impact of theUnited Kingdom'sdecision to leave the EU and uncertainty relating to the terms and timing of such separation), disruptions relating to man-made and natural disasters and pension plan costs.

Doctors demo 3Shape TRIOS intraoral scanner with AI scan

The 3Shape TRIOS intraoral scanner has an “AI Scan” feature that enables it to use artificial intelligence to make scanning easier. With AI Scan activated, TRIOS ...

Dr Lambert Stumpel demos AI scan in 3Shape TRIOS intraoral scanner

The award-winning 3Shape TRIOS intraoral scanner now features AI scan. AI scan automatically removes soft tissue while you scan to make your scanning ...

3Shape VP, Rune Fisker talks about AI

Rune Fisker discusses new TRIOS intraoral scanner feature AI scanning. Dr. Lambert Stempel test drives the new feature.

Guide to set-up Dentistry.AI in your practice

Dentistry.AI is a cloud-based artificial intelligence technology to detect dental caries on bitewings x-rays. Please refer to this video to install Dentistry.AI window's ...

New AI tech can scan your face to 'read' your emotions - TomoNews

BOSTON, MASSACHUSETTS — New tech developed by a US-based AI company can scan your face and read your emotions. SOURCES:The Guardian, MIT ...

Dental Monitoring System https://www.straightsmilesolutions.com/

StraightSmile Solutions® is an orthodontic consulting company that directly services dentists and their unique needs

3Shape scanners and software help ramp up production and grow dental lab's business

Hamid Babaeian, founder Pacific .

Medit Seoul Seminar Oct. 2018

On October 20th Medit had the pleassure to host an open seminar in Seoul. The info sessions for lab technicians and dental hygenists included CAD/CAM topics ...

Dental Monitoring with Kirsten

DentalCareXtra are excited to announce we now offer Dental Monitoring for helping track your Invisalign and Braces progress. Less visits and faster treatment ...

Videos de imagem tridimensional da face , realizada com o Scanner Artec 3D.